The CEA/PCI ratio is a superior prognosticator than mCOREP for colorectal cancer patients with peritoneal carcinomatosis

The CEA/PCI ratio is a superior prognosticator than mCOREP for colorectal cancer patients with peritoneal carcinomatosis

Background: The CEA/PCI ratio, which evaluates tumour marker and burden, has been demonstrated as a prognosticator for patients with colorectal cancer with peritoneal carcinomatosis. The aim of this study was to compare the CEA/PCI ratio with the Modified Colorectal Peritoneal Score (mCOREP) for ove...

Full description

Bibliographic Details
Main Authors: Phelopatir Anthony, MD, MS, Shoma Barat, BSc, MSc, Nima Ahmadi, MBBS, FRACS, David Lawson Morris, MBChB, FRACS
Format: Article
Language:English
Published: Elsevier 2024-06-01
Series:Surgery Open Science
Subjects:
Carcinoembryonic antigen
Peritoneal carcinomatosis
Colorectal cancer
Metastases
Prognosis
Online Access:http://www.sciencedirect.com/science/article/pii/S2589845024000472

Internet

http://www.sciencedirect.com/science/article/pii/S2589845024000472

Similar Items